Floatz logo

Abt-301

Colorectal Neoplasms

PfizerPhase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
73/ 100

Competitive context

118 Active assets in the Colorectal Neoplasms cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Janssen Research & Development, LLC
Phase 4BBB
Eloxatin
Peking University Cancer Hospital & Institute
Phase 4BBB
FLUOROURACILUM
Rutgers, The State University of New Jersey
Phase 4BBB
Irinotecan
Shanghai Zhongshan Hospital
Phase 4BBB
Capecitabine
Rutgers, The State University of New Jersey
Phase 4BB

View all 50 →

Same molecule, other indications

Abt-301 is also rated in:

Metastatic Colorectal CancerDormant
B
Indicative ·
63 / 100
View asset →
Metastatic MelanomaDormant
CCC
Indicative ·
54 / 100
View asset →
Rectal CancerDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →